Aveanna Healthcare Holdings Inc

Aveanna Healthcare Holdings Inc(AVAH)股票分析

$12.340

-0.292 (-2.37%)收盘时

Loading chart…
最高
12.720
开盘
12.650
成交量加权均价
12.44
成交量
2.33M
市值
492.49M
最低
12.250
成交额
28.94M
企业价值/息税折旧摊销前利润(TTM)
10.42

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas.

AI 分析 of Aveanna Healthcare Holdings Inc (AVAH)

持有

Aveanna Healthcare is currently a hold. The stock has a current price of $12.25, which is below the analyst price target of $15, suggesting potential upside. However, the RSI is at 32.085, indicating that the stock is oversold, which could mean a price rebound is possible. The recent insider selling has increased by 675.38%, which raises concerns about the stock's immediate outlook. Therefore, while there is potential for long-term gains, the current market sentiment and technical indicators suggest caution.

估值指标

Aveanna Healthcare Holdings Inc(AVAH)当前预期市盈率为 13.32,5 年平均预期市盈率为 37.40。

预期市盈率

合理
5 年均值 P/E
37.40
当前P/E
13.32
高估
140.10
低估
-65.29

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
11.87
当前EV/EBITDA
10.42
高估
13.41
低估
10.32

预期市销率

严重高估
5 年均值 P/S
0.41
当前P/S
0.93
高估
0.65
低估
0.17

Alphio AI 对 AVAH 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%AVAH

$6.77

情景价格

基

基准

基准 · 50%AVAH

$6.66

情景价格

悲

悲观

悲观 · 25%AVAH

$6.42

情景价格

持有 AVAH 的大户

B

Braidwell LP

+ 持有AVAH

+15.28%

3个月收益率

J

Jaunty Global Limited

+ 持有AVAH

-1.42%

3个月收益率

事件时间线

2026-08-20 (ET)

21:00:00

RBC Capital Prices Deal Within $11.65-$11.90 Range

20:00:00

US Treasury Yields Rise, Dow Drops Over 700 Points

16:30:00

Aveanna Healthcare Launches Secondary Offering of 15 Million Shares

2026-08-13 (ET)

07:30:00

Aveanna Reports Q2 Revenue of $670.48M, Exceeds Expectations

07:30:00

Aveanna Raises FY26 Adjusted EBITDA Outlook to Over $365M

资讯

AVAH 常见问题 —— 由 Alphio AI 解答

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

Aveanna Healthcare is currently a hold. The stock has a current price of $12.25, which is below the analyst price target of $15, suggesting potential upside. However, the RSI is at 32.085, indicating that the stock is oversold, which could mean a price rebound is possible. The recent insider selling has increased by 675.38%, which raises concerns about the stock's immediate outlook. Therefore, while there is potential for long-term gains, the current market sentiment and technical indicators suggest caution.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易